Papers

4

Total Citations

331

H-Index

4

About

Dr. Karim Touijer is a leading urologic surgeon and researcher whose work has profoundly shaped the prevention of thromboembolic complications and the advancement of robotic surgery. He is best known for his pivotal role in establishing evidence-based guidelines for deep vein thrombosis (DVT) prophylaxis in urology, as demonstrated by his authorship of the highly cited AUA Best Practice Statement (160 citations) and a landmark multi-institutional study on symptomatic DVT and pulmonary embolism after robotic prostatectomy (146 citations). These contributions have set the standard for perioperative patient safety. More recently, Dr. Touijer has been at the forefront of evaluating next-generation robotic platforms. His pioneering prospective comparative analysis of the Da Vinci and Hugo RAS systems for partial nephrectomy (2024) is already gaining significant attention, while his leadership of the international RUPTURE Project—a Delphi consensus on tumor rupture during robotic partial nephrectomy—is establishing critical definitions and management protocols for a rare but serious complication. Through this blend of guideline creation and innovation in robotic surgery, Dr. Touijer continues to drive safer, more effective urologic care.

Research Focus

Key Achievements

4
H-Index
4
Papers
331
Total Citations
83
Avg Citations/Paper
🏆 Most Cited Paper
AUA Best Practice Statement for the Prevention of Deep Vein Thrombosis in Patients Undergoing Urologic Surgery
160 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 75
🏛 Institutions: American Urological Association, Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago